Publication: The role for high flow nasal cannula as a respiratory support strategy in adults: a clinical practice guideline
dc.contributor.author | Bram Rochwerg | en_US |
dc.contributor.author | Sharon Einav | en_US |
dc.contributor.author | Dipayan Chaudhuri | en_US |
dc.contributor.author | Jordi Mancebo | en_US |
dc.contributor.author | Tommaso Mauri | en_US |
dc.contributor.author | Yigal Helviz | en_US |
dc.contributor.author | Ewan C. Goligher | en_US |
dc.contributor.author | Samir Jaber | en_US |
dc.contributor.author | Jean Damien Ricard | en_US |
dc.contributor.author | Nuttapol Rittayamai | en_US |
dc.contributor.author | Oriol Roca | en_US |
dc.contributor.author | Massimo Antonelli | en_US |
dc.contributor.author | Salvatore Maurizio Maggiore | en_US |
dc.contributor.author | Alexandre Demoule | en_US |
dc.contributor.author | Carol L. Hodgson | en_US |
dc.contributor.author | Alain Mercat | en_US |
dc.contributor.author | M. Elizabeth Wilcox | en_US |
dc.contributor.author | David Granton | en_US |
dc.contributor.author | Dominic Wang | en_US |
dc.contributor.author | Elie Azoulay | en_US |
dc.contributor.author | Lamia Ouanes-Besbes | en_US |
dc.contributor.author | Gilda Cinnella | en_US |
dc.contributor.author | Michela Rauseo | en_US |
dc.contributor.author | Carlos Carvalho | en_US |
dc.contributor.author | Armand Dessap-Mekontso | en_US |
dc.contributor.author | John Fraser | en_US |
dc.contributor.author | Jean Pierre Frat | en_US |
dc.contributor.author | Charles Gomersall | en_US |
dc.contributor.author | Giacomo Grasselli | en_US |
dc.contributor.author | Gonzalo Hernandez | en_US |
dc.contributor.author | Sameer Jog | en_US |
dc.contributor.author | Antonio Pesenti | en_US |
dc.contributor.author | Elisabeth D. Riviello | en_US |
dc.contributor.author | Arthur S. Slutsky | en_US |
dc.contributor.author | Renee D. Stapleton | en_US |
dc.contributor.author | Daniel Talmor | en_US |
dc.contributor.author | Arnaud W. Thille | en_US |
dc.contributor.author | Laurent Brochard | en_US |
dc.contributor.author | Karen E.A. Burns | en_US |
dc.contributor.other | Alfred Health | en_US |
dc.contributor.other | IAME Infection Antimicrobials Modelling Evolution | en_US |
dc.contributor.other | Centro de Investigación Biomédica en Red de Enfermedades Respiratorias | en_US |
dc.contributor.other | Keenan Research Centre for Biomedical Science | en_US |
dc.contributor.other | Li Ka Shing Knowledge Institute | en_US |
dc.contributor.other | Deenanath Mangeshkar Hospital and Research Center, Pune | en_US |
dc.contributor.other | Fondazione Policlinico Universitario Agostino Gemelli IRCCS Università Cattolica del Sacro Cuore | en_US |
dc.contributor.other | CHU Fattouma-Bourguiba | en_US |
dc.contributor.other | Università Cattolica del Sacro Cuore, Rome | en_US |
dc.contributor.other | McMaster University | en_US |
dc.contributor.other | CHU Montpellier | en_US |
dc.contributor.other | The University of Queensland | en_US |
dc.contributor.other | Università degli Studi di Milano | en_US |
dc.contributor.other | Université Paris-Est Créteil | en_US |
dc.contributor.other | Complejo Hospitalario de Toledo | en_US |
dc.contributor.other | Hôpital Henri Mondor | en_US |
dc.contributor.other | Università degli Studi di Foggia | en_US |
dc.contributor.other | Shaare Zedek Medical Center | en_US |
dc.contributor.other | AP-HP Assistance Publique - Hopitaux de Paris | en_US |
dc.contributor.other | Centre Hospitalier Universitaire de Poitiers | en_US |
dc.contributor.other | Monash University | en_US |
dc.contributor.other | Instituto do Coracao do Hospital das Clinicas | en_US |
dc.contributor.other | University of Toronto | en_US |
dc.contributor.other | University Health Network University of Toronto | en_US |
dc.contributor.other | Faculte de Medecine et de Pharmacie de l'Universite de Poitiers | en_US |
dc.contributor.other | Universite d'Angers | en_US |
dc.contributor.other | Hospital Universitari Vall d'Hebron | en_US |
dc.contributor.other | Hospital Universitari de Bellvitge | en_US |
dc.contributor.other | Faculty of Medicine, Siriraj Hospital, Mahidol University | en_US |
dc.contributor.other | University of Vermont | en_US |
dc.contributor.other | Hebrew University of Jerusalem | en_US |
dc.contributor.other | University of G. d'Annunzio Chieti and Pescara | en_US |
dc.contributor.other | Hopital Louis-Mourier | en_US |
dc.contributor.other | The Prince Charles Hospital | en_US |
dc.contributor.other | Hôpital Saint-Louis | en_US |
dc.contributor.other | Chinese University of Hong Kong | en_US |
dc.contributor.other | Harvard Medical School | en_US |
dc.contributor.other | Sorbonne Universite | en_US |
dc.contributor.other | Cardiopulmonary Research in Intensive Care and Toxicology | en_US |
dc.date.accessioned | 2020-12-28T06:06:52Z | |
dc.date.available | 2020-12-28T06:06:52Z | |
dc.date.issued | 2020-12-01 | en_US |
dc.description.abstract | © 2020, Springer-Verlag GmbH Germany, part of Springer Nature. Purpose: High flow nasal cannula (HFNC) is a relatively recent respiratory support technique which delivers high flow, heated and humidified controlled concentration of oxygen via the nasal route. Recently, its use has increased for a variety of clinical indications. To guide clinical practice, we developed evidence-based recommendations regarding use of HFNC in various clinical settings. Methods: We formed a guideline panel composed of clinicians, methodologists and experts in respiratory medicine. Using GRADE, the panel developed recommendations for four actionable questions. Results: The guideline panel made a strong recommendation for HFNC in hypoxemic respiratory failure compared to conventional oxygen therapy (COT) (moderate certainty), a conditional recommendation for HFNC following extubation (moderate certainty), no recommendation regarding HFNC in the peri-intubation period (moderate certainty), and a conditional recommendation for postoperative HFNC in high risk and/or obese patients following cardiac or thoracic surgery (moderate certainty). Conclusions: This clinical practice guideline synthesizes current best-evidence into four recommendations for HFNC use in patients with hypoxemic respiratory failure, following extubation, in the peri-intubation period, and postoperatively for bedside clinicians. | en_US |
dc.identifier.citation | Intensive Care Medicine. Vol.46, No.12 (2020), 2226-2237 | en_US |
dc.identifier.doi | 10.1007/s00134-020-06312-y | en_US |
dc.identifier.issn | 14321238 | en_US |
dc.identifier.issn | 03424642 | en_US |
dc.identifier.other | 2-s2.0-85096111314 | en_US |
dc.identifier.uri | https://repository.li.mahidol.ac.th/handle/20.500.14594/60549 | |
dc.rights | Mahidol University | en_US |
dc.rights.holder | SCOPUS | en_US |
dc.source.uri | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85096111314&origin=inward | en_US |
dc.subject | Medicine | en_US |
dc.title | The role for high flow nasal cannula as a respiratory support strategy in adults: a clinical practice guideline | en_US |
dc.type | Article | en_US |
dspace.entity.type | Publication | |
mu.datasource.scopus | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85096111314&origin=inward | en_US |